How Compounding Pharmacies Fill Critical Gaps in Pediatric Drug Development Processes: Suggested Regulatory Changes to Meet Future Challenges

Drugs administered to children in the United States fall into two broad categories: (1) those that have followed the US Food and Drug Administration (US-FDA) pediatric drug approval process and are marketed as finished dosage forms with pediatric labeling; and (2) all others, many of which are used...

Descripción completa

Detalles Bibliográficos
Autores principales: MacArthur, Robert B., Ashworth, Lisa D., Zhan, Keming, Parrish, Richard H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777176/
https://www.ncbi.nlm.nih.gov/pubmed/36553327
http://dx.doi.org/10.3390/children9121885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777176/
https://www.ncbi.nlm.nih.gov/pubmed/36553327
http://dx.doi.org/10.3390/children9121885

Ejemplares similares